Package 52856-505-22

Brand: emflaza

Generic: deflazacort
NDC Package

Package Facts

Identity

Package NDC 52856-505-22
Digits Only 5285650522
Product NDC 52856-505
Product ID 52856-505_604ae0b3-a373-40c0-b585-419abeac74eb
Description

13 mL in 1 BOTTLE (52856-505-22)

Marketing

Marketing Status
Marketed Since 2019-08-30
Brand emflaza
Generic deflazacort
Sample Package No

Linked Drug Pages (1)

EMFLAZA ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "604ae0b3-a373-40c0-b585-419abeac74eb", "openfda": {"nui": ["N0000175576", "N0000175450"], "unii": ["KR5YZ6AE4B"], "rxcui": ["153098", "153880", "1870950", "1870952", "1870954", "1870956", "1870958", "1870960", "1870964", "1870968"], "spl_set_id": ["31b347d2-f156-4055-9d8f-7cf0df420296"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "manufacturer_name": ["PTC Therapeutics, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "13 mL in 1 BOTTLE (52856-505-22)", "package_ndc": "52856-505-22", "marketing_start_date": "20190830"}], "brand_name": "EMFLAZA", "product_id": "52856-505_604ae0b3-a373-40c0-b585-419abeac74eb", "dosage_form": "SUSPENSION", "pharm_class": ["Corticosteroid Hormone Receptor Agonists [MoA]", "Corticosteroid [EPC]"], "product_ndc": "52856-505", "generic_name": "deflazacort", "labeler_name": "PTC Therapeutics, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "EMFLAZA", "active_ingredients": [{"name": "DEFLAZACORT", "strength": "22.75 mg/mL"}], "application_number": "NDA208685", "marketing_category": "NDA", "marketing_start_date": "20180910", "listing_expiration_date": "20261231"}